{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:56:53Z","timestamp":1781794613948,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016345","name":"Wuhan University Renmin Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cellsig.2026.112506","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:56:23Z","timestamp":1774972583000},"page":"112506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RNF130 inhibits the proliferation, migration and invasion of osteosarcoma through DAB1 mediated suppression of the PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"144","author":[{"given":"Wenda","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.cellsig.2026.112506_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21196985","article-title":"Bone microenvironment and osteosarcoma metastasis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112506_bb0015","article-title":"Pten in osteosarcoma: recent advances and the therapeutic potential","volume":"1874","author":"Zheng","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10.1016\/j.cellsig.2026.112506_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","article-title":"Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs","volume":"500","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112506_bb0025","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra2103423","article-title":"New horizons in the treatment of osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"New. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112506_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112506_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1670","article-title":"Wnt5b drives osteosarcoma stemness, chemoresistance and metastasis","volume":"14","author":"Perkins","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112506_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pbiomolbio.2025.07.001","article-title":"Advances and challenges in the treatment of osteosarcoma","volume":"197","author":"Wang","year":"2025","journal-title":"Prog. Biophys. Mol. Bio."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112506_bb0045","article-title":"The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence","volume":"1879","author":"Alhasan","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6467","key":"10.1016\/j.cellsig.2026.112506_bb0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112506_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082385","article-title":"The ubiquitin-proteasome system in tumor metabolism","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112506_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092235","article-title":"The ubiquitin proteasome system in genome stability and cancer","volume":"13","author":"Morgan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cellsig.2026.112506_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101203","article-title":"The dialogue between the ubiquitin-proteasome system and autophagy: implications in ageing","volume":"64","author":"Sun-Wang","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cellsig.2026.112506_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117210","article-title":"Status and role of the ubiquitin-proteasome system in renal fibrosis","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112506_bb0075","first-page":"255","article-title":"The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases","volume":"3","author":"Wang","year":"2006","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112506_bb0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2215-0366(19)30520-6","article-title":"The ubiquitin proteasome system and schizophrenia","volume":"7","author":"Luza","year":"2020","journal-title":"Lancet Psychiat."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112506_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tcb.2024.11.011","article-title":"Targeting the ubiquitin proteasome system in cancer stem cells","volume":"35","author":"Atta","year":"2025","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-03985-z","article-title":"P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization","volume":"21","author":"Sheng","year":"2023","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112506_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","article-title":"The ubiquitin-proteasome system in breast cancer","volume":"29","author":"Han","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0100","article-title":"Targeting the ubiquitin-proteasome system and recent advances in cancer therapy","volume":"13","author":"Spano","year":"2024","journal-title":"Cells-Basel"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0110","article-title":"The RING finger protein family in health and disease","volume":"7","author":"Cai","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0115","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13727","article-title":"Ring finger protein family in leukemia (review)","volume":"33","author":"Wang","year":"2026","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112506_bb0120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ecco-jcc\/jjw023","article-title":"E3 ubiquitin ligase RNF183 is a novel regulator in inflammatory bowel disease","volume":"10","author":"Yu","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cellsig.2026.112506_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115482","article-title":"RNF207 promotes the proliferation, migration and invasion of osteosarcoma through KCNQ1 mediated activation of ERK\/MEK signaling pathway","volume":"165","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112506_bb0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCRESAHA.122.321938","article-title":"RNF130 regulates LDLR availability and plasma LDL cholesterol levels","volume":"132","author":"Clifford","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellsig.2026.112506_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0669-2","article-title":"Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact","volume":"11","author":"Li","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112506_bb0140","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCRESAHA.123.322555","article-title":"RNF130 adds further complexity to the regulation of LDL receptor activity","volume":"132","author":"Robert","year":"2023","journal-title":"Circ. Res."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112506_bb0145","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.7150\/jca.98044","article-title":"Prognostic and immunotherapeutic significances of m2 macrophage-related genes signature in lung cancer","volume":"15","author":"Wu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.cellsig.2026.112506_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109985","article-title":"RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination","volume":"117","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05803-6","article-title":"SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K\/AKT\/mTOR signaling in osteosarcoma","volume":"22","author":"Huang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02146-8","article-title":"ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0165","article-title":"HMGCL activates autophagy in osteosarcoma through \u03b2-HB mediated inhibition of the PI3K\/AKT\/mTOR signaling pathway","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0170","article-title":"ESPN activates ZEB1-mediated EMT through the PI3K\/AKT\/mTOR axis to promote osteosarcoma metastasis","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Transl. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112506_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155207","article-title":"Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy","volume":"21","author":"Cersosimo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112506_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070791","article-title":"The role of ubiquitination in osteosarcoma development and therapies","volume":"14","author":"Mao","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112506_bb0185","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cell.2024.12.005","article-title":"Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution","volume":"188","author":"Valle-Inclan","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112506_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105684","article-title":"Advances in targeted therapy for osteosarcoma based on molecular classification","volume":"169","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112506_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1148\/radiol.240703","article-title":"Calcified osteosarcoma lung metastases","volume":"312","author":"Spinnato","year":"2024","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-023-00917-3","article-title":"A tumor microenvironment-based prognostic index for osteosarcoma","volume":"30","author":"Wu","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","article-title":"Genome-informed targeted therapy for osteosarcoma","volume":"9","author":"Sayles","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112506_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104575","article-title":"Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: recent advancements","volume":"206","author":"Adewuyi","year":"2025","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112506_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040506","article-title":"Present advances and future perspectives of molecular targeted therapy for osteosarcoma","volume":"17","author":"Shaikh","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0220","article-title":"A single-cell and spatially resolved atlas of human osteosarcomas","volume":"17","author":"Zheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112506_bb0225","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2022.12.012","article-title":"Evolutionarily conserved regulators of tau identify targets for new therapies","volume":"111","author":"Kim","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.cellsig.2026.112506_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107300","article-title":"PI3K\/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression","volume":"206","author":"Guo","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112506_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112506_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204819","article-title":"MIR497HG-derived miR-195 and miR-497 mediate tamoxifen resistance via PI3K\/AKT signaling in breast cancer","volume":"10","author":"Tian","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2026.112506_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112665","article-title":"PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K\/FOXO3a pathway","volume":"148","author":"Du","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112506_bb0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/2159-8290.CD-14-0595","article-title":"Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO","volume":"5","author":"Sonoshita","year":"2015","journal-title":"Cancer Discov."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112506_bb0255","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1080\/15384101.2020.1823730","article-title":"Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:50:04Z","timestamp":1781794204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S0898656826001580"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112506","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF130 inhibits the proliferation, migration and invasion of osteosarcoma through DAB1 mediated suppression of the PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112506"}}